Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 615.41B, Johnson & Johnson(JNJ) trades at $255.50. The stock has a price-to-earnings ratio of 28.97 and currently yields dividends of 2.10%.
As of 2026-07-22, Johnson & Johnson(JNJ) stock has fluctuated between $251.21 and $256.29. The current price stands at $255.50, placing the stock +1.7% above today's low and -0.3% off the high.
The Johnson & Johnson(JNJ)'s current trading volume is 8.62M, compared to an average daily volume of 8.15M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $164.23.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $164.23.
JNJ News
...
Key Points Vanguard Health Care ETF offers a lower expense ratio and higher dividend yield than Invesco Pharmaceuticals ETF Invesco Pharmaceuticals ETF has co...
The marketing clearance encompasses multiple general surgery procedures. The medical technology giant will initiate a commercial rollout with select U.S. facil...
Analyst ratings
73%
of 26 ratingsMore JNJ News
Shares of Johnson & Johnson (JNJ) are marching higher after the healthcare company’s robotic surgery device was approved by the U.S. Food and Drug Administratio...
Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might aff...
Johnson & Johnson (JNJ) on Wednesday announced that the FDA granted its De Novo authorization for the company’s soft tissue robotic system, Ottava, to handle mu...
Johnson & Johnson announced that the U.S. Food and Drug Administration, FDA, has granted De Novo authorization for the OTTAVA Robotic Surgical System. The syste...
Johnson & Johnson stock has delivered a 66.6% gain over the past 5 years, yet current checks flag a mixed picture on value, with the Discounted Cash Flow (DCF)...
Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories By Vandita Jadeja Published Jul 21, 11:00AM EDT Quick Read JNJ's 64-y...
Jim Cramer: Alibaba Is “Still the Best Way to Play China” Despite Being Down 18% YTD By Thomas Richmond Published Jul 20, 1:57PM EDT Quick Read Cramer calls B...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.